Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients
- 1 August 2003
- journal article
- review article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 15 (S4) , S21-S25
- https://doi.org/10.1038/sj.ijir.3901032
Abstract
Low testosterone levels are common in both men and women with human immunodeficiency virus (HIV) infection and may contribute to loss of lean body mass and AIDS wasting. Causes of low testosterone levels are complex and may include chronic illness, HIV infection and its complications, medications used to treat HIV and opportunistic diseases, and normal aging-related declines. In the majority of studies addressing the use of testosterone treatment in HIV-infected patients, testosterone has been found to help prevent loss of lean body and muscle mass. Whether the combination of exercise and testosterone is more effective in preventing loss of lean body mass than either therapy alone is not yet clear and warrants further study. In addition to its effects on body composition, testosterone treatment results in improved mood and libido in HIV-infected women and increased bone mineral density in HIV-infected men. Testosterone may thus make a valuable contribution to the treatment of HIV-infected individuals.Keywords
This publication has 21 references indexed in Scilit:
- Prevalence of Hypogonadism among Men with Weight Loss Related to Human Immunodeficiency Virus Infection Who Were Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Acute and Long-Term Effects of AIDS and Injection Drug Use on Gonadal FunctionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Acute and Long-Term Effects of AIDS and Injection Drug Use on Gonadal FunctionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Relation of Lean Body Mass to Health-Related Quality of Life in Persons With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infectionThe American Journal of Medicine, 1999
- Sustained Anabolic Effects of Long‐Term Androgen Administration in Men with AIDS WastingClinical Infectious Diseases, 1999
- Testosterone therapy for clinical symptoms of hypogonadism in eugonadal men with AIDSInternational Journal of STD & AIDS, 1998
- MALE HORMONE REPLACEMENT THERAPY INCLUDING “ANDROPAUSE”Endocrinology and Metabolism Clinics of North America, 1998
- Weight Loss as a Predictor of Survival and Disease Progression in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Endocrine disorders in men infected with human immunodeficiency virusThe American Journal of Medicine, 1988